Kemwell Biopharma acquires Cirrus Pharmaceuticals

Kemwell Biopharma, a leading global bio/pharmaceutical contract services company headquartered in Bangalore, India announced today that it has acquired Cirrus Pharmaceuticals Inc., a contract development services company based in Research Triangle Park, NC, USA.

Cirrus is a highly reputed contract product development organization. Cirrus has been serving the needs of the global pharmaceutical industry for over 15 years. Since its inception in 1997, Cirrus has established a strong reputation for its development expertise in inhalation, parenteral, transdermal, topical and liquid dosage forms. It also offers stand-alone analytical services including stability studies.

"Kemwell’s corporate objective is to build a leading global bio/pharmaceutical contract services company," said Anurag Bagaria, Chairman and MD of Kemwell. "Cirrus will complement the existing contract services offered by Kemwell with early stage innovative product development. Kemwell will now provide customers with a complete solution from early development in the US to commercial manufacturing in Kemwell’s EMA, FDA and PMDA approved facilities in India and Sweden.”

Dr. Ninad Deshpanday, President R&D at Kemwell said, “With Cirrus’ development capabilities and Kemwell’s manufacturing expertise, we will be able to develop products with faster time-to-clinic and significant cost savings for our customers.”

Cirrus’ President, Dr. Anthony Hickey added, "This acquisition is a testament to the tremendous value our talented employees have created for Cirrus over the past several years. The acquisition will transform Cirrus into a global player in R&D services by significantly strengthening our capabilities in inhalation R&D and increasing offerings in other areas such as oral solids dosage forms. The Cirrus team looks forward to joining the Kemwell family and continuing to provide the high customer satisfaction it always has.”

About Kemwell
Kemwell Biopharma Pvt Ltd with its head office in Bangalore, India is a pure play contract development and manufacturing company. The company develops and manufactures bio/pharmaceuticals for some of the world’s top pharmaceutical companies, including Bayer, Boehringer Ingelheim, GlaxoSmithKline, Merck KGaA, Novartis and Pfizer. Kemwell is one of India’s largest CDMO of bio/ pharmaceuticals with over 30 years’ experience. The company employs more than 1200 employees worldwide and has seven production facilities and state-of-the art research and development laboratories in India and Sweden. Kemwell is an approved bio/pharmaceutical manufacturer in over 80 countries including the American, European, Japanese and Indian markets.

About Cirrus
Cirrus Pharmaceuticals is a contract research and product development company located in Research Triangle Park, North Carolina, USA. Cirrus can assist or manage projects as needed by providing a broad array of R&D services including physical and chemical characterization, formulation development, stability testing, container/closure selection, process development, scale-up and technical transfer for inhaled, nasal, oral, parenteral, topical and transdermal products. Services can include submission-ready regulatory documentation and assistance with regulatory submission questions.

Enter your email address: Delivered by FeedBurner